The Complete Guide

Tadalafil (Generic Cialis): The Complete Guide

Why it lasts so much longer than the others, how the daily and as-needed regimens differ, and everything worth knowing before you order it.

Complete Guide · ~19 min read · Last updated July 2026

What Tadalafil Actually Is

Tadalafil is a PDE5 inhibitor — the same drug class as sildenafil, working through the same underlying mechanism of prolonging cyclic GMP signaling to sustain blood flow in erectile tissue. It's the active ingredient sold under the brand name Cialis®, and it's chemically distinct from sildenafil, not a variant or reformulation of it. The two most important practical differences are duration — tadalafil's effects last dramatically longer — and dosing structure, since tadalafil is the only one of the four ingredients in this catalog with a genuine daily-use regimen alongside its as-needed use.

On this site, tadalafil is sold as Megalis 20, a 20mg as-needed tablet — the catalog's second flagship listing after Sildatron-100, and the natural choice for anyone who's used Cialis before or wants a longer window than sildenafil typically provides.

History and Development

Tadalafil's development history is a joint-venture story rather than a single-company one. ICOS Corporation, a biotechnology company based in Bothell, Washington, and Eli Lilly and Company formed a 50/50 joint venture called Lilly ICOS LLC in October 1998, specifically to develop and commercialize PDE5 inhibitors. Tadalafil was the product of that partnership, and the joint-venture structure itself is worth noting — ICOS brought the underlying compound and much of the early research, while Lilly brought the manufacturing scale, regulatory experience, and global commercial infrastructure needed to actually launch a drug against an already-established competitor. Profits, losses, and distributions from the venture were allocated based on ownership interests, with Lilly ICOS holding rights to tadalafil for North America and Europe while Lilly held exclusive rights to the rest of the world, paying royalties back to the joint venture.

Tadalafil reached the European market first — the European Commission approved it for erectile dysfunction in November 2002, and Lilly ICOS began shipping it to European wholesalers in January 2003, several months ahead of its U.S. approval. By the third quarter of 2003, more than one million patients worldwide had already been treated with tadalafil, and the drug was available in more than 45 countries — a genuinely fast international rollout for a product still awaiting its largest single market. The FDA approved tadalafil in the United States on November 21, 2003, more than five years after sildenafil's 1998 approval had already established the category and built enormous brand recognition around the word "Viagra" specifically.

That timing gap mattered commercially, and Lilly ICOS's launch strategy reflected it directly. Rather than trying to out-market an already-dominant, culturally ubiquitous competitor, the U.S. launch leaned hard into the pharmacological difference: a February 2004 Super Bowl advertising campaign, a "Cialis Promise" free-trial program aimed specifically at men who'd never tried the drug, and a relentless focus on duration as the headline reason to switch or to try tadalafil first. It worked faster than a typical pharmaceutical launch might suggest — within weeks of the national ad campaign, tadalafil had already surpassed the third major PDE5 inhibitor, vardenafil, in new prescriptions, despite vardenafil having launched earlier. Within about two years of its European launch, tadalafil had reached $1 billion in global sales and had become the leading ED treatment by market share in France specifically, a genuine commercial success against an already-entrenched competitor rather than a token also-ran in the category.

The Two Regimens: As-Needed vs. Daily

This is the single most important thing that separates tadalafil from the other three PDE5 inhibitors in this catalog: it's available in two genuinely different regimens, not just different strengths of the same approach. The as-needed regimen — what Megalis 20 is formulated for — works the same way sildenafil, vardenafil, and avanafil do: take it in anticipation of sexual activity, at a higher single-dose strength, and its effects taper off over the following window. This is the regimen most people mean when they talk about "taking a Cialis" in the same casual sense they'd talk about taking a Viagra — a single dose, timed around an occasion.

The daily regimen is a different approach entirely: a much lower dose, taken every day regardless of anticipated activity, intended to maintain a steady low level of the drug in your system so that you're not timing a dose around a specific occasion at all. Proponents of the daily approach point to spontaneity as the core benefit — no advance planning required, no window to track, no decision to make in the moment. The trade-off is continuous exposure: where an as-needed dose means the drug is only in your system when you've chosen to take it, a daily regimen means it's present essentially all the time, which changes the calculus around drug interactions and cardiovascular risk factors in a way that's genuinely worth a prescriber's input rather than a self-directed decision. This isn't a "starter dose" of the as-needed approach, and it's not simply "the same drug but gentler" — it's a distinct, ongoing regimen with its own risk-benefit profile. The catalog on this site is built around the as-needed use case; Megalis 20 is not formulated or priced for daily use, and nothing in this guide should be read as encouragement to use an as-needed product as a substitute for the daily regimen.

Why It's Called "The Weekend Pill"

Tadalafil's nickname in casual conversation — "the weekend pill" — comes directly from its pharmacokinetics. Where sildenafil's effects are commonly discussed in terms of several hours, tadalafil's window extends dramatically longer, commonly cited at up to 36 hours. That's the entire basis for the nickname: a single as-needed dose taken on a Friday evening could still be relevant well into Saturday, without needing to re-dose. This single characteristic is tadalafil's primary competitive differentiator against sildenafil and is usually the deciding factor for people choosing between the two.

It's worth being precise about what "up to 36 hours" means in practice: it describes the outer window during which the drug remains pharmacologically active in the body, not a guarantee of a specific duration for every individual dose or every person. Individual response varies. What's consistent is the relative comparison — tadalafil's duration is a multiple of sildenafil's, not a marginal improvement.

Strength and Dosing

As-needed tadalafil is typically available from 5mg to 20mg, with Megalis 20 sitting at the top of that range. The daily regimen uses much lower strengths — commonly 2.5mg to 5mg — reflecting the fact that daily dosing is designed around sustained low-level exposure rather than a single strong effect.

Our full tadalafil strength guide walks through the as-needed decision framework in more depth, including why a first-time user has more to gain from starting below the maximum than from starting at it.

Food Interactions and Alcohol

One of tadalafil's genuine practical advantages over sildenafil is a less food-sensitive absorption profile — tadalafil can generally be taken with or without food without the same well-documented high-fat-meal delay that affects sildenafil, which is part of why some people find it more convenient to plan around. Alcohol interacts with tadalafil the same general way it does with the other PDE5 inhibitors: heavy use can independently contribute to erectile difficulty and can compound side effects like flushing or dizziness, without being an acute, nitrate-level danger on its own.

Tadalafil Beyond ED: BPH

Tadalafil has a second FDA-approved indication that sildenafil doesn't share in the same form: benign prostatic hyperplasia, or BPH — a common, non-cancerous enlargement of the prostate gland that causes urinary symptoms, particularly in older men. At a low daily dose, tadalafil is FDA-approved to treat the signs and symptoms of BPH, a use that's mechanistically distinct from its ED indication even though it's the same molecule and, in some patients, the same daily regimen addresses both conditions simultaneously. This dual-indication status is part of why the daily tadalafil regimen exists as a serious, medically-recognized approach rather than a marketing variant of the as-needed product — it genuinely serves a different, FDA-recognized clinical purpose for some patients. This isn't something the catalog on this site addresses directly, since Megalis 20 is formulated for as-needed ED use, but it's a useful piece of context for understanding why tadalafil's regimen structure looks the way it does.

Safety and the Nitrate Warning

Alpha-blockers and certain blood pressure medications can also interact with tadalafil, generally through an additive blood-pressure-lowering effect, and this interaction is also relevant for longer given tadalafil's extended presence in the body. Common, generally mild side effects include headache, back pain, muscle aches, flushing, and nasal congestion — the muscle and back pain profile is somewhat more specific to tadalafil than to the other three PDE5 inhibitors, and is thought to relate to PDE5 inhibition in tissue beyond the vascular system it's primarily targeting, since PDE5 is present in some skeletal muscle tissue as well as vascular tissue. These effects are generally described as mild and self-limiting, but they're worth knowing about in advance simply so they don't come as a surprise or get mistaken for something more serious.

As with every medication in this catalog, an erection lasting more than four hours (priapism) is a rare but genuine medical emergency requiring immediate attention, not a wait-and-see situation — and given tadalafil's longer duration profile generally, it's worth being especially attentive to this specific warning sign rather than assuming a prolonged effect is simply the drug "working as expected." Our full ED medication safety guide covers the complete interaction picture across the entire catalog.

Megalis 20: The Catalog Listing

Megalis 20 is a generic tadalafil 20mg tablet, formulated for as-needed use — the catalog's second-most-ordered product and the natural choice for anyone specifically seeking tadalafil's longer duration over sildenafil's shorter window. Full detail, including exact pricing and pack-size structure, is in our dedicated Megalis 20 guide.

How Tadalafil Differs From the Other Three

Duration is tadalafil's headline difference — a window measured in tens of hours rather than several, and the only ingredient in this catalog with a legitimate daily-use regimen alongside its as-needed option. Its food-interaction profile is more forgiving than sildenafil's, and its FDA-approved second indication (BPH) is unique among the four. Where sildenafil, vardenafil, and avanafil are all fundamentally single-purpose, single-regimen medications in this catalog's context, tadalafil is genuinely more versatile — which is also part of why the daily regimen decision specifically benefits from prescriber involvement rather than self-directed ordering. See our brand-name decoder for the full catalog compared side by side, and our sildenafil guide for the direct point of comparison most people are actually weighing tadalafil against.

Myths About Tadalafil, Specifically

The most persistent myth about tadalafil is that its long duration means constant, unwanted arousal for the full window — it doesn't. Like every PDE5 inhibitor in this catalog, tadalafil amplifies the body's response to stimulation rather than generating arousal independently of it; the extended window means the drug remains available to respond to stimulation for longer, not that it produces a continuous effect regardless of context. A second myth: that the daily low-dose regimen is simply "tadalafil for people who need it more often" — it's a structurally different regimen with a different risk profile, not a more serious or more advanced version of the as-needed approach.

Frequently Asked Questions